Acurx Pharma Falls 25% : comparemela.com

Shares of late-stage biopharma company Acurx Pharmaceuticals, Inc. (ACXP) are falling more than 25 percent on Wednesday morning trade, despite reporting positive comparative data from Ibezapolstat from Phase 2b trial in CDI patients.

Related Keywords

China , , Federal Reserve , View More , Stock Alert , Ccxp , Acurx Pharmaceuticals , Nc ,